# Esperance Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/esperance-pharmaceuticals

- Industry: Healthcare Specialists
- Headquarters: Houston, US
- Website: www.esperancepharma.com
- Total disclosed funding: $5.7M
- Latest round: Series B (Jun 1, 2011)
- Investors on record: 7

## About

Founded in 2006 and based in Texas, US, Esperance Pharmaceuticals, Inc. develops therapeutics that can kill cancer cells without harming normal cells. The company offers EP-100, an anticancer drug for the treatment of ovarian cancer and breast cancer.

## Funding rounds

- Series B, Jun 1, 2011, $5.7M — Advantage Capital, Research Corporation Technologies, BVM Capital, Enhanced Capital, Sanofi, Adams and Reese, Themelios Ventures

## Investors

- Advantage Capital — Series B
- Research Corporation Technologies (https://capitalatlas.ai/funds/research-corporation-technologies) — Series B
- BVM Capital (https://capitalatlas.ai/funds/bvm-capital) — Series B
- Enhanced Capital (https://capitalatlas.ai/funds/enhanced-capital) — Series B
- Sanofi — Series B
- Adams and Reese — Series B
- Themelios Ventures — Series B